| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Controller and CAO
2 companies
Frederick Munsch is SVP, Controller and CAO at BLCO, with reported holdings spanning 2 companies. Frederick Munsch's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.1M at current prices.
Frederick Munsch's largest disclosed position is in BLCO as SVP, Controller and CAO, worth about $918K. The BLCO filings lean toward selling, a net 164,915 shares.
Frederick Munsch has 22 Form 4 filings on record from November 2021 to October 2026, across 2 companies: SVP, Controller and CAO at Bausch + Lomb (BLCO), 2022–2026; SVP, Controller and CAO at Bausch Health Companies (BHC), 2021–2022.
The 33 reported transactions were 15 tax withholdings, 10 stock awards, 3 option exercises and 3 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $3.2M.
The largest open-market sale was 112,015 shares of BLCO at an average $20.48 on October 29, 2026, about $2.3M.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.